1. Home
  2. HDL vs INVA Comparison

HDL vs INVA Comparison

Compare HDL & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HDL
  • INVA
  • Stock Information
  • Founded
  • HDL 2016
  • INVA 1996
  • Country
  • HDL Singapore
  • INVA United States
  • Employees
  • HDL N/A
  • INVA N/A
  • Industry
  • HDL Restaurants
  • INVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HDL Consumer Discretionary
  • INVA Health Care
  • Exchange
  • HDL Nasdaq
  • INVA Nasdaq
  • Market Cap
  • HDL 1.2B
  • INVA 1.3B
  • IPO Year
  • HDL 2024
  • INVA 2004
  • Fundamental
  • Price
  • HDL $19.03
  • INVA $19.37
  • Analyst Decision
  • HDL
  • INVA Strong Buy
  • Analyst Count
  • HDL 0
  • INVA 4
  • Target Price
  • HDL N/A
  • INVA $40.25
  • AVG Volume (30 Days)
  • HDL 2.7K
  • INVA 685.9K
  • Earning Date
  • HDL 08-26-2025
  • INVA 11-05-2025
  • Dividend Yield
  • HDL N/A
  • INVA N/A
  • EPS Growth
  • HDL 197.81
  • INVA N/A
  • EPS
  • HDL 0.09
  • INVA 0.53
  • Revenue
  • HDL $805,433,000.00
  • INVA $370,229,000.00
  • Revenue This Year
  • HDL $14.91
  • INVA $8.17
  • Revenue Next Year
  • HDL $12.41
  • INVA $12.06
  • P/E Ratio
  • HDL $23.08
  • INVA $36.34
  • Revenue Growth
  • HDL 9.65
  • INVA 12.02
  • 52 Week Low
  • HDL $14.18
  • INVA $16.67
  • 52 Week High
  • HDL $30.00
  • INVA $22.00
  • Technical
  • Relative Strength Index (RSI)
  • HDL 42.25
  • INVA 40.54
  • Support Level
  • HDL $18.80
  • INVA $19.11
  • Resistance Level
  • HDL $19.60
  • INVA $21.11
  • Average True Range (ATR)
  • HDL 0.27
  • INVA 0.49
  • MACD
  • HDL -0.06
  • INVA -0.15
  • Stochastic Oscillator
  • HDL 9.56
  • INVA 12.94

About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. It mission is to become a global integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.

About INVA Innoviva Inc.

Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.

Share on Social Networks: